Innovative medical foods developed by a biotechnology company in Guizhou's Shuanglong Airport Economic Zone have hit the market, marking a breakthrough in preoperative care.
These specialized products, approved by the National Medical Products Administration, address metabolic disturbances caused by prolonged fasting, restoring bodily balance effectively and enhancing patients' resilience.
These medical foods, developed by Guizhou Jinjiu Biotech Co, promise safe and efficient energy and electrolyte replenishment. They also help accelerate recovery, reduce hospital stays, and significantly improve postoperative metabolism and clinical outcomes.
This milestone propels the company into cross-industry development and signifies Guizhou province's advancement in the medical foods sector, showcasing the province's innovative research capabilities. The company's success underscores a bright future in the medical foods field and bolsters confidence in Guizhou's industrial innovation.
With these products already on the market and poised for clinical application expansion, the company anticipates a 10 percent annual increase in revenue. The company is also actively establishing Guizhou's sole medical food production base. With a projected investment exceeding 100 million yuan ($14.06 million), the base is set to be operational by the first half of next year.
The company focuses on intensive R&D efforts and crafting cutting-edge high-tech products to advance Guizhou's healthcare industry. This bolsters the province's strategic development and solidifies its position as a hub for medical innovation.